Lataa...
Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers
INTRODUCTION: Current attempts to identify genetic modifiers of BRCA1 and BRCA2 associated risk have focused on a candidate gene approach, based on knowledge of gene functions, or the development of large genome-wide association studies. In this study, we evaluated 24 SNPs tagged to 14 candidate gen...
Tallennettuna:
Päätekijät: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
BioMed Central
2010
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3046447/ https://ncbi.nlm.nih.gov/pubmed/21114847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2785 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|